Financial Results

Claris Lifesciences Limited Un-Audited Financial Results for the Quarter Ended 30th September 2014

New Delhi, Nov 14,2014 Claris Lifesciences Ltd. (CLL) announced its quarterly un-audited financial results for the quarter ended 30th September…

10 years ago

Wockhardt Q2 net slumps 98 % as US regulatory action bites

Mumbai, November 2014: Drug-maker Wockhardt saw a 98 per cent drop in its net profit for the three months ended September…

10 years ago

Clariant Chemicals sales up 47% in second quarter

New Delhi, November 2014 – Clariant Chemicals (India) Ltd, a specialty chemicals producer, registered a 47 per cent rise in…

10 years ago

Aarti Industries Ltd. Q2FY15 Results

Mumbai, November 2014 — Q2FY15 Total Income at Rs. 761.16 crore, Y-o-Y growth 18 % — Q2FY15 Net Profit at…

10 years ago

Ranbaxy turns around, posts Rs. 478-cr profit in Q2

India and Europe drove the base biz, while a new generic drug pushed the US sales New Delhi, November 2014…

10 years ago

Pfizer’s $11 billion buyback plan deflates AstraZeneca bid hopes

London – U.S. drugmaker Pfizer is to continue buying back stock, with the board authorizing a new $11 billion share…

10 years ago

Benefit of Ranbaxy deal to accrue in few years: Sun Pharma

New Delhi, September 30, 2014 – It will take a “few years” for Sun Pharma to realise the benefits of its $4…

10 years ago

RNA Therapeutics Market is Expected to Reach $1.2 Billion, Globally, by 2020 – Allied Market Research

New Delhi, September 25, 2014 – A new report by Allied Market Research, titled “RNA Therapeutics Market (technology, applications, end…

10 years ago

Cipla registers Rs.295 crore profit in first quarter

Mumbai, August 20, 2014 – Drugmaker Cipla registered a profit after tax at Rs.295 crore during the three months ended…

10 years ago

Fortis Narrows loss to Rs.45.8 Crore in Q1

NEW DELHI, AUGUST 9, 2014: Fortis Healthcare has narrowed its losses in the first quarter of this fiscal. The company…

10 years ago